KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Change in Intangibles (2020 - 2024)

Historic Change in Intangibles for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Q3 2024 value amounting to $129000.0.

  • Aurinia Pharmaceuticals' Change in Intangibles rose 36071.43% to $129000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $253000.0, marking a year-over-year increase of 541.67%. This contributed to the annual value of $16000.0 for FY2019, which is N/A changed from last year.
  • As of Q3 2024, Aurinia Pharmaceuticals' Change in Intangibles stood at $129000.0, which was up 36071.43% from $84000.0 recorded in Q2 2024.
  • In the past 5 years, Aurinia Pharmaceuticals' Change in Intangibles registered a high of $162000.0 during Q1 2023, and its lowest value of -$83000.0 during Q4 2021.
  • Moreover, its 4-year median value for Change in Intangibles was $28000.0 (2023), whereas its average is $36454.5.
  • Over the last 5 years, Aurinia Pharmaceuticals' Change in Intangibles had its largest YoY gain of 50000.0% in 2020, and its largest YoY loss of 15000.0% in 2020.
  • Aurinia Pharmaceuticals' Change in Intangibles (Quarter) stood at -$4000.0 in 2020, then tumbled by 1975.0% to -$83000.0 in 2021, then skyrocketed by 133.73% to $28000.0 in 2023, then skyrocketed by 360.71% to $129000.0 in 2024.
  • Its Change in Intangibles was $129000.0 in Q3 2024, compared to $84000.0 in Q2 2024 and $12000.0 in Q1 2024.